In Friday’s Wall Street session, Insmed Inc (NASDAQ:INSM) shares traded at $69.69, up 1.06% from the previous session.
INSM stock price is now -7.16% away from the 50-day moving average and -5.67% away from the 200-day moving average. The market capitalization of the company currently stands at $12.67B.
With the price target of $100, RBC Capital Mkts recently initiated with Outperform rating for Insmed Inc (NASDAQ: INSM). On April 23, 2024, Truist recently initiated its ‘Buy’ rating on the stock quoting a target price of $48, while ‘Wolfe Research’ rates the stock as ‘Outperform’
In other news, Lewis William, Chair and CEO sold 6,830 shares of the company’s stock on Apr 15 ’25. The stock was sold for $479,177 at an average price of $70.16. Upon completion of the transaction, the Chair and CEO now directly owns 233,924 shares in the company, valued at $16.3 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 15 ’25, Officer Lewis William bought 6,830 shares of the business’s stock. A total of $478,933 was incurred on buying the stock at an average price of $70.12. A total of 2.31% of the company’s stock is owned by insiders.
During the past 12 months, Insmed Inc has had a low of $21.92 and a high of $84.91. As of last week, the company has a debt-to-equity ratio of 4.60, a current ratio of 5.45, and a quick ratio of 5.12. The fifty day moving average price for INSM is $75.068 and a two-hundred day moving average price translates $73.8792 for the stock.
The latest earnings results from Insmed Inc (NASDAQ: INSM) was released for 2024-12-31. The net profit margin was -251.24% and return on equity was -890.75% for INSM. The company reported revenue of $104.44 million for the quarter, compared to $83.69 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 24.79 percent. For the current quarter, analysts expect INSM to generate $92.09M in revenue.
